Solasia Pharma Kk (4597) Press Release
Consolidated Financial Results for the Six Months Ended June 30, 2026 (Under IFRS)
Earlier from Solasia Pharma Kk
- Solasia Announces Launch of Darvias® in Japan
- Solasia Pharma K K: Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2022 (under IFRS)
- Solasia Pharma K K: Announces Topline Data from Phase III AGENT Study of SP-05(arfolitixorin)
- Solasia Pharma K K: Announces Capital and Business Alliance with Nippon Kayaku Co., Ltd.